(Q50228683)

English

Involvement of HMGB1 mediated signalling pathway in diabetic retinopathy: evidence from type 2 diabetic rats and ARPE-19 cells under diabetic condition.

scientific article published on 16 October 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 February 2018

http://europepmc.org/abstract/MED/24133029

Involvement of HMGB1 mediated signalling pathway in diabetic retinopathy: evidence from type 2 diabetic rats and ARPE-19 cells under diabetic condition. (English)

1 reference

Europe PubMed Central

27 February 2018

http://europepmc.org/abstract/MED/24133029

diabetic retinopathy

1 reference

based on heuristic

inferred from title

author name string

Xiao-Li Chen

1

1 reference

Europe PubMed Central

27 February 2018

http://europepmc.org/abstract/MED/24133029

Xue-Dong Zhang

2

1 reference

Europe PubMed Central

27 February 2018

http://europepmc.org/abstract/MED/24133029

Ying-Yuan Li

3

1 reference

Europe PubMed Central

27 February 2018

http://europepmc.org/abstract/MED/24133029

Xue-Mei Chen

4

1 reference

Europe PubMed Central

27 February 2018

http://europepmc.org/abstract/MED/24133029

De-Rong Tang

5

1 reference

Europe PubMed Central

27 February 2018

http://europepmc.org/abstract/MED/24133029

Rui-Jin Ran

6

1 reference

Europe PubMed Central

27 February 2018

http://europepmc.org/abstract/MED/24133029

language of work or name

0 references

publication date

16 October 2013

1 reference

Europe PubMed Central

27 February 2018

http://europepmc.org/abstract/MED/24133029

number of pages

6

1 reference

based on heuristic

inferred from page(s)

British Journal of Ophthalmology

1 reference

Europe PubMed Central

27 February 2018

http://europepmc.org/abstract/MED/24133029

97

1 reference

Europe PubMed Central

27 February 2018

http://europepmc.org/abstract/MED/24133029

12

1 reference

Europe PubMed Central

27 February 2018

http://europepmc.org/abstract/MED/24133029

1598-1603

1 reference

Europe PubMed Central

27 February 2018

http://europepmc.org/abstract/MED/24133029

Is diabetic retinopathy an inflammatory disease?

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303736

21 January 2018

Immunological mechanisms in the pathogenesis of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303736

21 January 2018

Prevalence and risk factors of diabetic retinopathy in Chongqing pre-diabetes patients

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303736

21 January 2018

Inflammation in diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303736

21 January 2018

VEGF164Is Proinflammatory in the Diabetic Retina

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303736

21 January 2018

High-mobility group box family of proteins: ligand and sensor for innate immunity

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303736

21 January 2018

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303736

21 January 2018

Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303736

21 January 2018

HMGB1 is a therapeutic target for sterile inflammation and infection

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303736

21 January 2018

Upregulation of RAGE and its ligands in proliferative retinal disease

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303736

21 January 2018

Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia are regulated by the receptor for advanced glycation end-products (RAGE).

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303736

21 January 2018

High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina.

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303736

21 January 2018

The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303736

21 January 2018

Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303736

21 January 2018

Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303736

21 January 2018

A possible role of acrolein in diabetic retinopathy: involvement of a VEGF/TGFβ signaling pathway of the retinal pigment epithelium in hyperglycemia

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303736

21 January 2018

Identifiers

10.1136/BJOPHTHALMOL-2013-303736

1 reference

Europe PubMed Central

27 February 2018

http://europepmc.org/abstract/MED/24133029

1 reference

Europe PubMed Central

27 February 2018

http://europepmc.org/abstract/MED/24133029

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50228683&oldid=1775100112"